Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
jarmoluk / Pixabay

Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says

According to a story from Healio, the results of a randomized trial suggest that patients with eosinophilic esophagitis are likely to experience rapid relapse if they stop treatment. This was…

Continue Reading Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug
Pexels / Pixabay

Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug

According to a story from Science Daily, the University of California San Francisco's Benioff Children's Hospitals have successfully treated an infant with juvenile myelomonocytic leukemia. The drug used for treatment…

Continue Reading Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug
Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

FDA Approves a Combination of Drugs for Diffuse Large B-cell Lymphoma

  Diffuse large B-cell lymphoma  (DLBCL) is a common type of non-Hodgkins lymphoma. World Pharma News recently reported that the FDA approved the first chemoimmunotherapy, Polivy, for DLBCL in combination with…

Continue Reading FDA Approves a Combination of Drugs for Diffuse Large B-cell Lymphoma
Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
RoyBuri / Pixabay

Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1

According to a story from wearegreenbay.com, a team of scientists associated with the University of Wisconsin, Madison are undertaking a project that will help improve the effectiveness of research related…

Continue Reading Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
stanvpetersen / Pixabay

Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

According to a story from the Warwick Beacon, the first ever primary immunodeficiency (PI) awareness and fundraising walk in Rhode Island's history was held recently at Warwick City Park. The…

Continue Reading Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
pixel2013 / Pixabay

The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU

According to a story from BioSpace, Janssen Pharmaceutical Companies recently announced that the European Commission (EC) has expanded the approved indication of the company's drug ustekinumab (marketed as Stelara). This…

Continue Reading The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy
mwooten / Pixabay

Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from newswise.com, the American Neuromuscular Foundation has recently awarded a grant to Dr. Karissa Gable. This grant will go towards a research project headed by Dr.…

Continue Reading Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy